Ct Healthcare Trust (red) (CTHT) Share Price, News & Analysis

Company Overview

CT Healthcare Trust plc (LON: CTHT) is a United Kingdom–listed investment trust that concentrates on the healthcare and life sciences sectors. The company’s principal activity is investing in quoted healthcare equities and related instruments with the objective of delivering long‑term capital growth for its shareholders through exposure to companies involved in pharmaceuticals, biotechnology, medical devices, diagnostics and healthcare services.

The trust builds a diversified portfolio across a range of healthcare sub‑sectors and geographies, typically taking positions in established and emerging companies that the board and investment manager consider to have attractive growth prospects, innovative technologies or strong market positions. Investment selection emphasizes sector expertise and fundamental analysis, and the portfolio may include companies listed in developed and, where justified, selected emerging markets.

CT Healthcare Trust is governed by a board of directors responsible for oversight of strategy, risk and shareholder interests and appoints an external investment manager to implement its investment policy. The company is traded on the London Stock Exchange, providing UK and international investors with a vehicle to gain targeted exposure to the global healthcare market. Publicly available corporate reports and regulatory filings provide further details on its strategy, portfolio holdings and governance.

Key Stats

• Today's Range: 129 to 131.80
• 50-Day Range: N/A
• 52-Week Range: 122.43 to 142.80
• Volume: 81,578 shs
• Average Volume: 236,753 shs
• Market Capitalization: £72.88 million
• P/E Ratio: N/A
• Dividend Yield: 4.10%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Real Estate
• Industry: Investment Trusts & Mutual Funds
• Sub-Industry: N/A
• Current Symbol: LON:CTHT
• CIK: N/A
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: -£50.58 million
• Price / Sales: -1.44
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 56,151,000
• Free Float: N/A
• Market Cap: £72.88 million
• Optionable: N/A
• Beta: N/A